The Authors' reply
- Maureen Watt1,
- Stuart Mealing1,
- Mealing Eaton1,
- Mark Sculpher1,
- Pascale Brasseur2,
- Rachele Busca2,
- Nicolo Piazza3,
- Stephen Palmer4,
- Neil Moat5
- 1Health Economics, Oxford Outcomes Ltd, Oxford, UK
- 2Reimbursement CardioVascular Europe, Medtronic International Trading Sarl, Tolochenaz, Switzerland
- 3Cardiovascular Surgery, Munich Heart Centre, Munich, Germany
- 4Centre for Health Economics, University of York, York, USA
- 5Department of Cardiac Surgery, Royal Brompton Hospital, London, UK
- Correspondence to Ms Maureen Watt, Health Economics, Oxford Outcomes Ltd, Seacourt Tower, West Way, Botley, Oxford OX2 0JJ, UK; mozzawatt{at}gmail.com
-
Contributors All authors contributed to the design, parameterisation and validation of the economic model. MW and SM constructed the economic model and prepared the manuscript. All authors provided significant comments on the content.
The Authors' reply: Van Baal argues that we have under-estimated the cost associated with transcatheter aortic valve implantation (TAVI) and as a result, we have generated an overly-optimistic picture of its cost effectiveness. …








